Results 91 to 100 of about 1,239 (187)

Theodor Bilharz' 200th birthday. [PDF]

Infect Dis Poverty
Richter J.
europepmc   +1 more source

Rational approach to drug discovery for human schistosomiasis. [PDF]

Int J Parasitol Drugs Drug Resist, 2021
LoVerde PT, Alwan SN, Taylor AB, Rhodes J, Chevalier FD, Anderson TJ, McHardy SF.   +6 more
europepmc   +1 more source

Pharmacological assessment of drugs retained in the 1^st and 24^th WHO Essential Medicines List (1977-2025). [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Bindel LJ, Seifert R.
europepmc   +1 more source

The big picture : Parasites, People and the Path to Ending Schistosomiasis. [PDF]

EMBO Rep
Mutapi F, Woolhouse MEJ.
europepmc   +1 more source

Ranitidine protects Müller cells against ferroptosis in diabetic retinopathy by regulating the AKT1/GSK3β pathway. [PDF]

Indian J Ophthalmol
He W, Qi J, Liu Z, Mei Y.
europepmc   +1 more source

<i>Schistosoma</i> infection as a cause of myeloradiculopathy: case report from Mozambique and systematic review. [PDF]

Front Med (Lausanne)
Buque H, Arroz N, Lorenzo E, Manjate A, Passanduca A, Sidat M, Nzwalo H.   +6 more
europepmc   +1 more source

Analysis of the Physicochemical Properties of Anti-Schistosomal Compounds to Identify Next-Generation Leads. [PDF]

ACS Med Chem Lett
González Cabrera D, Keiser J, Spangenberg T.   +2 more
europepmc   +1 more source

Potency of anti-trematode in inhibiting cathepsin-2L and cathepsin-5L of <i>Fasciola gigantica</i> using homology, docking, and molecular dynamics. [PDF]

Open Vet J
Vanda H, Athaillah F, Sari WE, Frengki F, Nurliana N, Hambal M.   +5 more
europepmc   +1 more source

Therapeutic challenges of schistosomiasis: mechanisms of action and current limitations. [PDF]

J Parasit Dis
Balahbib A, El Omari N, Lghazi H, Hatoufi K, El Atki Y, Bouyahya A, Amarir F.   +6 more
europepmc   +1 more source

In Silico Comparison of Bioactive Compounds Characterized from Azadirachta indica with an FDA-Approved Drug against Schistosomal Agents: New Insight into Schistosomiasis Treatment. [PDF]

Molecules
Oyinloye BE, Shamaki DE, Agbebi EA, Onikanni SA, Ubah CS, Aruleba RT, Dao TNP, Owolabi OV, Idowu OT, Mathenjwa-Goqo MS, Esan DT, Ajiboye BO, Omotuyi OI.   +12 more
europepmc   +1 more source